Erratum to: “Autophagy inhibition enhances sensitivity of alpelisib in PI3K–mutated non-small cell lung cancer” (Biomedicine & Pharmacotherapy, (2025), 192, C, (118620), (S0753332225008145), 10.1016/j.biopha.2025.118620)

Research output: Contribution to journalComment/debate

Abstract

The publisher regrets the affiliation for one of the authors was published incorrectly. The affiliation for author g, "Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, 16247, Republic of Korea," was stated incorrectly. The correct affiliation is "Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea." The publisher would like to apologise for any inconvenience caused.

Original languageEnglish
Article number118651
JournalBiomedicine and Pharmacotherapy
Volume192
DOIs
StatePublished - Nov 2025

Bibliographical note

Publisher Copyright:
© 2025 The Authors.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum to: “Autophagy inhibition enhances sensitivity of alpelisib in PI3K–mutated non-small cell lung cancer” (Biomedicine & Pharmacotherapy, (2025), 192, C, (118620), (S0753332225008145), 10.1016/j.biopha.2025.118620)'. Together they form a unique fingerprint.

Cite this